Real-life experience with the implementation of DLL3 staining and the subsequent treatment with rovalpituzumab tesirine in heavily pretreated SCLC patients
Hochmair, M.J., Weinlinger, C., Fabikan, H., Koger, R., Krenbeck, D., Huemer, F., Illini, O.M., Kulaksiz, M., Valipour, A., Burghuber, O.C.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
EP02.01-008 Clinicopathological Features of Rare but Targetable Mutations in Surgically Resected Lung Carcinomas
Zacharias, M., Konjic, S., Absenger, G., Hochmair, M.J., Fabikan, H., Weinlinger, C., Illini, O., Jost, P.J., Schlintl, V., Wurm, R., Lindenmann, J., Fediuk, M., Brcic, L., Terbuch, A.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
63PReal-life experience with the implementation of DLL3 staining and the subsequent treatment with rovalpituzumab tesirine in heavily pretreated SCLC patients
Hochmair, M J, Weinlinger, C, Fabikan, H, Koger, R, Krenbeck, D, Huemer, F, Illini, O M, Kulaksiz, M, Valipour, A, Burghuber, O C
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
EP08.02-122 Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP)
Illini, O., Fabikan, H., Swalduz, A., Krenbek, D., Vikström, A., Schumacher, M., Dudnik, E., Studnicka, M., Öhman, R., Wurm, R., Wannesson, L., Peled, N., Kian, W., Bar, J., Daher, S., Addeo, A., Rotem, O., Pall, G., Zer, A., Saad, A., Cufer, T., Sorotsky, H.G., Hashemi, S.M.S., Mohorcic, K., Stoff, R., Rovitsky, Y., Keren-Rosenberg, S., Winder, T., Weinlinger, C., Valipour, A., Hochmair, M.J.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
P2.14-46 Treatment Observations and Clinical Experience with Lorlatinib in Pretreated ALK and ROS1 Rearranged NSCLC Patients
Hochmair, M.J., Weinlinger, C., Fabikan, H., Illini, O., Krenbek, D., Setinek, U., Watzka, S., Koger, R., Meilinger, M., Absenger, G., Wanke, M., Semmelweis, C., Rauter, M., Valipour, A.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
P2.13-03 Real-Life Experience with Brigatinib in Pretreated EML4-ALK Translocated NSCLC Patients
Hochmair, M., Naber, J., Schwab, S., Setinek, U., Krenbek, D., Holzer, M., Fabikan, H., Watzka, S., Koger, R., Fazekas, A., Bitterlich, E., Valipour, A., Burghuber, O.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
P3.03-024 Real-Life Experience and Clinical Characterization of BRAF V600E Mutation in Austrian NSCLC Patients
Schwab, S., Setinek, U., Krenbek, D., Watzka, S., Gasser, S., Huemer, F., Kapfhammer, I., Fabikan, H., Hauptmann-Repitz, E., Burghuber, O., Hochmair, M.
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article